News | July 08, 2022
Evonik launches non-animal-derived collagen platform for medical device applications
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
These medicines have low risk of hypoglycemia, provide beta cell protection, offer cardio-renal benefits and are safe for patients with kidney or liver conditions and senior citizens
Site Enhances New Modality CRDMO Platform Capacity for Customers
Medicfibers in collaboration with AIIMS New Delhi, has developed an antimicrobial solution Viroclog that when applied as a coating on textiles, provides long-lasting protection against HAI by reducing virus, bacteria, fungi survival on fabric
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems
The AICVD tool can predict the risk of cardiovascular disease.
Subscribe To Our Newsletter & Stay Updated
